Kezar Life Sciences (KZR) Short Interest Ratio & Short Volume → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free KZR Stock Alerts $0.80 +0.01 (+1.89%) (As of 04:00 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Kezar Life Sciences Short Interest DataCurrent Short Volume3,820,000 sharesPrevious Short Volume3,570,000 sharesChange Vs. Previous Month+7.00%Dollar Volume Sold Short$3.09 millionShort Interest Ratio / Days to Cover5.1Last Record DateApril 15, 2024Outstanding Shares72,800,000 sharesPercentage of Shares Shorted5.25%Today's Trading Volume495,601 sharesAverage Trading Volume689,991 sharesToday's Volume Vs. Average72% Short Selling Kezar Life Sciences ? Sign up to receive the latest short interest report for Kezar Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKZR Short Interest Over TimeKZR Days to Cover Over TimeKZR Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Kezar Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20243,820,000 shares $3.09 million +7.0%N/A5.1 $0.81 3/31/20243,570,000 shares $3.22 million +5.6%N/A5 $0.90 3/15/20243,380,000 shares $2.97 million +6.3%N/A4.9 $0.88 2/29/20243,180,000 shares $3.34 million +6.0%N/A4.5 $1.05 2/15/20243,000,000 shares $2.53 million -1.6%N/A4.3 $0.84 1/31/20243,050,000 shares $3.02 million +2.4%N/A4.7 $0.99 Get the Latest News and Ratings for KZR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kezar Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,980,000 shares $2.77 million +9.6%N/A4.7 $0.93 12/31/20232,720,000 shares $2.58 million +0.7%N/A3.8 $0.95 12/15/20232,700,000 shares $2.26 million +7.6%N/A3.8 $0.84 11/30/20232,510,000 shares $2.10 million -8.7%N/A4.1 $0.84 11/15/20232,750,000 shares $2.18 million +25.0%N/A5.2 $0.79 10/31/20232,200,000 shares $1.59 million -24.9%N/A4.5 $0.72 10/15/20232,930,000 shares $2.80 million -0.7%N/A6.2 $0.96 9/30/20232,950,000 shares $3.51 million +1.0%N/A6.1 $1.19 9/15/20232,920,000 shares $3.77 million +21.7%N/A7.2 $1.29 8/31/20232,400,000 shares $3.58 million -2.8%N/A3.9 $1.49 8/15/20232,470,000 shares $3.80 million -1.6%N/A3.6 $1.54 7/31/20232,510,000 shares $5.62 million -6.0%N/A3.5 $2.24 7/15/20232,670,000 shares $6.49 million -4.0%N/A3.2 $2.43 6/30/20232,780,000 shares $6.81 million -12.0%N/A3 $2.45 6/15/20233,160,000 shares $8.34 million +10.1%N/A2.8 $2.64 5/31/20232,870,000 shares $7.98 million -2.4%N/A2.7 $2.78 5/15/20232,940,000 shares $8.85 million -14.8%N/A2.9 $3.01 4/30/20233,450,000 shares $8.38 million -6.3%N/A3.5 $2.43 4/15/20233,680,000 shares $8.76 million -30.6%N/A3.8 $2.38 3/31/20235,300,000 shares $16.59 million +8.4%N/A5.6 $3.13 3/15/20234,890,000 shares $22.54 million +13.2%N/A6.8 $4.61 2/28/20234,320,000 shares $27.17 million +3.4%N/A6.7 $6.29 2/15/20234,180,000 shares $27.42 million -5.6%N/A7 $6.56 1/31/20234,430,000 shares $31.76 million +14.5%N/A6.9 $7.17 1/15/20233,870,000 shares $26.47 million -37.0%N/A6 $6.84 12/30/20226,140,000 shares $43.23 million -4.5%N/A9.3 $7.04 12/15/20226,430,000 shares $43.60 million -0.3%N/A8.8 $6.78 11/30/20226,450,000 shares $50.37 million -2.3%N/A7.7 $7.81 11/15/20226,600,000 shares $52.93 million -7.3%N/A7.7 $8.02 10/31/20227,120,000 shares $53.51 million +10.9%N/A8.1 $7.52 10/15/20226,420,000 shares $53.61 million -13.0%N/A6.8 $8.35 9/30/20227,380,000 shares $63.54 million +3.4%N/A7.9 $8.61 9/15/20227,140,000 shares $70.19 million +2.3%N/A3.3 $9.83 8/31/20226,980,000 shares $71.75 million +0.4%N/A3.3 $10.28Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now KZR Short Interest - Frequently Asked Questions What is Kezar Life Sciences' current short interest? Short interest is the volume of Kezar Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 3,820,000 shares of KZR short. Learn More on Kezar Life Sciences' current short interest. What is a good short interest ratio for Kezar Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KZR shares currently have a short interest ratio of 5.0. Learn More on Kezar Life Sciences's short interest ratio. Which institutional investors are shorting Kezar Life Sciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Kezar Life Sciences: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Kezar Life Sciences' short interest increasing or decreasing? Kezar Life Sciences saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 3,820,000 shares, an increase of 7.0% from the previous total of 3,570,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Kezar Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Kezar Life Sciences: Equillium, Inc. (2.31%), HCW Biologics Inc. (0.05%), Immix Biopharma, Inc. (2.53%), SCYNEXIS, Inc. (2.75%), Mural Oncology plc (8.08%), Eagle Pharmaceuticals, Inc. (10.32%), Lantern Pharma Inc. (6.33%), Celularity Inc. (3.73%), Kronos Bio, Inc. (1.65%), Reneo Pharmaceuticals, Inc. (13.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Kezar Life Sciences stock? Short selling KZR is an investing strategy that aims to generate trading profit from Kezar Life Sciences as its price is falling. KZR shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kezar Life Sciences? A short squeeze for Kezar Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KZR, which in turn drives the price of the stock up even further. How often is Kezar Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KZR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Equillium Short Interest Data HCW Biologics Short Interest Data Immix Biopharma Short Interest Data SCYNEXIS Short Interest Data Mural Oncology Short Interest Data Eagle Pharmaceuticals Short Interest Data Lantern Pharma Short Interest Data Celularity Short Interest Data Kronos Bio Short Interest Data Reneo Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KZR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry